Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1 H-NMR Spectroscopy

In conclusion, a metabolomic approach appears to be a promising, noninvasive tool that could potentially contribute to predicting the efficacy of MS therapies.

http://link.springer.com/10.1007/s13311-019-00721-8

Source: Neurotherapeutics - February 28, 2019 Category: Neurology Source Type: research